Lonza Group Ltd

1LONN

Company Profile

  • Business description

    Lonza Group is a contract development and manufacturing organization, or CDMO. It operates under four segments: small molecules, biologics, cell & gene, and capsules & health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing services throughout the entire lifecycle of a product from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

  • Contact

    Muenchensteinerstrasse 38
    Basel4002
    CHE

    T: +41 613168111

    E: [email protected]

    https://www.lonza.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    18,686

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,820.306.40-0.07%
CAC 407,826.3175.94-0.96%
DAX 4024,244.77212.04-0.87%
Dow JONES (US)44,344.45306.19-0.69%
FTSE 1008,935.8239.84-0.44%
HKSE24,139.57111.200.46%
NASDAQ20,585.0145.65-0.22%
Nikkei 22539,569.6876.68-0.19%
NZX 50 Index12,686.6873.52-0.58%
S&P 5006,254.6625.80-0.41%
S&P/ASX 2008,580.109.10-0.11%
SSE Composite Index3,510.180.500.01%

Market Movers